Ranbaxy’s Malvinder Singh is now its chairmanDecember 19th, 2008 - 6:18 pm ICT by IANS
New Delhi, Dec 19 (IANS) Pharmaceutical major Ranbaxy’s chief executive and managing director Malvinder Mohan Singh will now also be its chairman, the company announced Friday.The Ranbaxy board was reconstituted during the day following the strategic alliance with Japan’s Daiichi Sankyo that was completed last month. Daiichi Sankyo now holds 63.92 percent of the Indian company’s equity share capital.
Singh has also become a member of the senior global management team of Daiichi Sankyo, a company statement said.
“The composition of the new board reflects the new ownership structure at Ranbaxy. The new board is dedicated to realising the benefits of the global partnership between Daiichi Sankyo and Ranbaxy in the creation and provision of innovative pharmaceutical products,” it added.
Atul Sobti will be the chief operating officer, while Takashi Shoda, president and chief executive officer of Daiichi Sankyo, Tsutomu Une, senior executive officer at the Japanese firm, and Sunil Godhwani, CEO and managing director of Religare Enterprises will be company directors.